Morris, Manning & Martin partner Carl Erhardt and associate Melissa Joyal advised a British company on its acquisition of a research group that conducts clinical trials for drug companies.
PHC Inc. sold its Pivotal Research Centers subsidiary to Premier Research Group PLC for $3 million, plus additional considerations that could push the total value of the deal to $5 million. The deal closed March 13. Erhardt and Joyal advised Premier Research.
Premier Research, based in the United Kingdom, conducts clinical research for drug makers and medical device makers. PHC, of Peabody, Mass., conducts business under the name Pioneer Behavioral Health and operates a dozen substance abuse-treatment facilities nationwide.